AVANTGEN, INC.

TGA BioServices, an Absorption Systems'​ Company, is an FDA inspected contract research laboratory providing the Pharmaceutical, Biotechnology and Research communities a comprehensive range of laboratory services in support of research and clinical studies. We offer the client a complete package of customized testing systems utilized in preclinical through Phase IV studies, all in compliance with cGLP and cGMP requirements.

We specialize in the development and validation of immunoassay systems for the detection of target molecules, antibody responses and quantification in total compliance with QA and cGMP standards.

TGA BioServices also offers in vivo mouse studies for the optimization of vaccine immunization schedules, dosing, adjuvant screening, immunogenicity testing for the release and stability of bulk and finished clinical product, as well as complete antibody development programs. Furthermore, we offer Guinea pig dermal sensitization testing for the identification of contact allergens. All programs are supervised by an in-house Institutional Animal Care and Use Committee (IACUC), while the facility is USDA registered and AAALAC accredited.

Other services provided include FACScan cell labeling studies, tissue culture, endotoxin testing, basic R&D activities, sample storage, specimen collection kits with on-site training, data management, protocol generation (SOP), database/statistical analysis and consultation. TGA BioServices has the credentials your project is searching for.

Our company is recognized for excellence in providing ISO 9001monoclonal and polyclonal antibodies, antigens, enzymes, and purified proteins to the research and medical diagnostic marketplace. Nearly all of our products are validated for usage in quantitative sandwich immunoassay and qualitative rapid testing.

We offer immunological reagents worldwide for diagnostics & research in the following disciplines:

Infectious Diseases (60)
Neuroscience (45)
Inflammation (43)
Veterinary (41)
Cardiac Markers (36)
Gangliosides & Globosides (33)
Tumor Markers (26)
Hormones (22)
Microbial & Plant Toxins (21)
Metabolic Syndrome (15)
Blood Coagulation and Anemia (12)
Biodefense (10)
Kidney Diseases (4)
Fertility and Pregnancy (2)


We are happy to inform you that Advanced ImmunoChemical is now offering a set of antibodies produced In vitro. In addition, some of our current antibodies are now available both as In vivo- and In vitro-produced products.

Monoclonal antibodies and mammalian antigens for detecting infectious diseases, cardiac biomarkers, and hormones.

Broad selection antibodies and inactivated viral antigens to detect Influenza A and B in clinical samples.
Monoclonal antibodies for the detection of biological threats and dangerous pathogens.

Biomarkers for cardiovascular disease prevention, risk assessment, and diagnostics.

Customers Include: Princeton University, Duke University School of Medicine, Columbia University Medical Center, CDC, National Institutes of Health, Naval Health Research Center, Los Alamos National Laboratory, US Army Medical Research Institute of Infectious Diseases, Sandia National Laboratories, Stanfored Medicine, NIST, NIMH, Harvard Medical School, Yale University School of Medicine, John Hopkins School of Medicine, Lawrence Livermore National Laboratory, and many more!

Advanced ImmunoChemical is a WBENC-certified woman-owned small business, since 1986.

Affinity Biologicals, Inc. is a primary manufacturer of products used worldwide in thrombosis and hemostasis research and diagnostics. Our products include an extensive line of antibodies, conjugates, antibody pairs for immunoassay of human and animal analytes, the VisuLize line of complete ELISA kits, and a full line of human plasma products including VisuDep Immune-Depleted Factor-Deficient Plasmas, VisuCal Calibrator Plasma and VisuCon Control Plasmas. Services include protein purification, antibody production, assay development, custom manufacturing including custom lyophilization and proficiency testing materials.

For more information please visit www.affinitybiologicals.com.

In 1976 Alister Voller, Mike Clark, and associates reported the successful and sensitive detection of plant viruses by ELISA. Two years earlier, Voller, Engvall, Bidwell and Huldt developed the microwell ELISA plate. This technology arrived just in time to test and select plants grown by tissue culture and to assist clean plant programs using one-way pass-through propagation methods. The rapid exploration and acceptance of ELISA created an immediate need for optimized, validated tests, for kits, for quality controlled antibodies, enzyme conjugates and accessories. Agdia, Inc. was formed to meet this need.

Agdia’s first tests were developed for common potato pathogens, i.e., the viruses, PVX, PVY, PLRV, PVS, PVM, PVA and the bacteria, ringrot [Cms] and blackleg [Eca]. Next, a Testing Service was developed to help those who needed testing results but did not want to perform the tests themselves. The products and services were an instant hit.

Agdia grew quickly as its products and services became known worldwide. In rapid succession many tests were developed for fruit, ornamental and field crops. And, significant advances were made in test formats and test type, including, the PathoScreen® test format, the potyvirus group test, membrane assays for viroids, nested PCR for phytoplasma, PCR virus group tests and ImmunoStrips®. All of this was possible only because a worldwide community of scientists and customers provided technology, biomaterials, plant samples and constant encouragement.

Agdia’s continuing focus on developing and performing tests for plant pathogens and dedication to confidential customer service and support have earned a special trust and place in the worldwide agricultural community. We value and treasure this trust. And, with each day, we dedicate ourselves anew to providing you with products and service that enable you to grow healthy crops with confidence.

American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay based products for the North American life science markets. Our origin began through an exclusive partnership with one European manufacturer and has since grown into a premier channel representing over 60 collaborating partners from around the globe. In 2007, we expanded our capabilities with the launch of our organically developed product line focused in the area of diabetes and obesity research while also remaining true to our roots by continuing to provide “Immunoassays Beyond the Ordinary.”

As the research and diagnostic endeavors of our customers continue to evolve, so does ALPCO’s commitment to providing high quality products and superior customer support. Over the years we’ve expanded our offering into applications for HPLC, LC-MS/MS, purified antibodies, recombinant proteins, flow cytometry reagents and recently launched our new STELLUX® line of chemiluminescent based detection systems in 2013. Additionally, our promise to provide optimal support continues to progress through a growing network of valuable online resources, collaborative relationships, and customized technical solutions. While our vision has evolved to serve a broader segment of life science research and healthcare professionals, our mission to deliver “Scientific Solutions for Life” remains the same.